Shopping Cart 0
Cart Subtotal
AED 0

Global Topotecan Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 17910

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 26864

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 35819

Details

Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types.

Scope of the Report:

The global Topotecan market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Topotecan.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Topotecan market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Topotecan market by product type and applications/end industries.

Market Segment by Companies, this report covers

GSK

Teva

Fresenius Kabi

Cipla

Sagent Pharmaceuticals

Mylan

Pfizer

Dr. Reddy's Laboratories

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Capsules

Injection

Market Segment by Applications, can be divided into

Ovarian Cancer

Lung Cancer

Other Cancer types

READ MORE

Table Of Content

Scope

Table of Contents

1 Topotecan Market Overview

1.1 Product Overview and Scope of Topotecan

1.2 Classification of Topotecan by Types

1.2.1 Global Topotecan Revenue Comparison by Types (2019-2024)

1.2.2 Global Topotecan Revenue Market Share by Types in 2018

1.2.3 Capsules

1.2.4 Injection

1.3 Global Topotecan Market by Application

1.3.1 Global Topotecan Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Ovarian Cancer

1.3.3 Lung Cancer

1.3.4 Other Cancer types

1.4 Global Topotecan Market by Regions

1.4.1 Global Topotecan Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Topotecan Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Topotecan Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Topotecan Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Topotecan Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Topotecan Status and Prospect (2014-2024)

1.5 Global Market Size of Topotecan (2014-2024)

2 Manufacturers Profiles

2.1 GSK

2.1.1 Business Overview

2.1.2 Topotecan Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GSK Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.2 Teva

2.2.1 Business Overview

2.2.2 Topotecan Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Teva Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.3 Fresenius Kabi

2.3.1 Business Overview

2.3.2 Topotecan Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Fresenius Kabi Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.4 Cipla

2.4.1 Business Overview

2.4.2 Topotecan Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Cipla Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.5 Sagent Pharmaceuticals

2.5.1 Business Overview

2.5.2 Topotecan Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sagent Pharmaceuticals Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.6 Mylan

2.6.1 Business Overview

2.6.2 Topotecan Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Mylan Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Topotecan Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.8 Dr. Reddy's Laboratories

2.8.1 Business Overview

2.8.2 Topotecan Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Dr. Reddy's Laboratories Topotecan Revenue, Gross Margin and Market Share (2017-2018)

3 Global Topotecan Market Competition, by Players

3.1 Global Topotecan Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Topotecan Players Market Share

3.2.2 Top 10 Topotecan Players Market Share

3.3 Market Competition Trend

4 Global Topotecan Market Size by Regions

4.1 Global Topotecan Revenue and Market Share by Regions

4.2 North America Topotecan Revenue and Growth Rate (2014-2019)

4.3 Europe Topotecan Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Topotecan Revenue and Growth Rate (2014-2019)

4.5 South America Topotecan Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Topotecan Revenue and Growth Rate (2014-2019)

5 North America Topotecan Revenue by Countries

5.1 North America Topotecan Revenue by Countries (2014-2019)

5.2 USA Topotecan Revenue and Growth Rate (2014-2019)

5.3 Canada Topotecan Revenue and Growth Rate (2014-2019)

5.4 Mexico Topotecan Revenue and Growth Rate (2014-2019)

6 Europe Topotecan Revenue by Countries

6.1 Europe Topotecan Revenue by Countries (2014-2019)

6.2 Germany Topotecan Revenue and Growth Rate (2014-2019)

6.3 UK Topotecan Revenue and Growth Rate (2014-2019)

6.4 France Topotecan Revenue and Growth Rate (2014-2019)

6.5 Russia Topotecan Revenue and Growth Rate (2014-2019)

6.6 Italy Topotecan Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Topotecan Revenue by Countries

7.1 Asia-Pacific Topotecan Revenue by Countries (2014-2019)

7.2 China Topotecan Revenue and Growth Rate (2014-2019)

7.3 Japan Topotecan Revenue and Growth Rate (2014-2019)

7.4 Korea Topotecan Revenue and Growth Rate (2014-2019)

7.5 India Topotecan Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Topotecan Revenue and Growth Rate (2014-2019)

8 South America Topotecan Revenue by Countries

8.1 South America Topotecan Revenue by Countries (2014-2019)

8.2 Brazil Topotecan Revenue and Growth Rate (2014-2019)

8.3 Argentina Topotecan Revenue and Growth Rate (2014-2019)

8.4 Colombia Topotecan Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Topotecan by Countries

9.1 Middle East and Africa Topotecan Revenue by Countries (2014-2019)

9.2 Saudi Arabia Topotecan Revenue and Growth Rate (2014-2019)

9.3 UAE Topotecan Revenue and Growth Rate (2014-2019)

9.4 Egypt Topotecan Revenue and Growth Rate (2014-2019)

9.5 Nigeria Topotecan Revenue and Growth Rate (2014-2019)

9.6 South Africa Topotecan Revenue and Growth Rate (2014-2019)

10 Global Topotecan Market Segment by Type

10.1 Global Topotecan Revenue and Market Share by Type (2014-2019)

10.2 Global Topotecan Market Forecast by Type (2019-2024)

10.3 Capsules Revenue Growth Rate (2014-2024)

10.4 Injection Revenue Growth Rate (2014-2024)

11 Global Topotecan Market Segment by Application

11.1 Global Topotecan Revenue Market Share by Application (2014-2019)

11.2 Topotecan Market Forecast by Application (2019-2024)

11.3 Ovarian Cancer Revenue Growth (2014-2019)

11.4 Lung Cancer Revenue Growth (2014-2019)

11.5 Other Cancer types Revenue Growth (2014-2019)

12 Global Topotecan Market Size Forecast (2019-2024)

12.1 Global Topotecan Market Size Forecast (2019-2024)

12.2 Global Topotecan Market Forecast by Regions (2019-2024)

12.3 North America Topotecan Revenue Market Forecast (2019-2024)

12.4 Europe Topotecan Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Topotecan Revenue Market Forecast (2019-2024)

12.6 South America Topotecan Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Topotecan Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Topotecan Picture

Table Product Specifications of Topotecan

Table Global Topotecan and Revenue (Million USD) Market Split by Product Type

Figure Global Topotecan Revenue Market Share by Types in 2018

Figure Capsules Picture

Figure Injection Picture

Table Global Topotecan Revenue (Million USD) by Application (2014-2024)

Figure Topotecan Revenue Market Share by Applications in 2018

Figure Ovarian Cancer Picture

Figure Lung Cancer Picture

Figure Other Cancer types Picture

Table Global Market Topotecan Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Table GSK Basic Information, Manufacturing Base and Competitors

Table GSK Topotecan Type and Applications

Table GSK Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Teva Basic Information, Manufacturing Base and Competitors

Table Teva Topotecan Type and Applications

Table Teva Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Fresenius Kabi Basic Information, Manufacturing Base and Competitors

Table Fresenius Kabi Topotecan Type and Applications

Table Fresenius Kabi Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Topotecan Type and Applications

Table Cipla Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Sagent Pharmaceuticals Topotecan Type and Applications

Table Sagent Pharmaceuticals Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Topotecan Type and Applications

Table Mylan Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Topotecan Type and Applications

Table Pfizer Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors

Table Dr. Reddy's Laboratories Topotecan Type and Applications

Table Dr. Reddy's Laboratories Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Global Topotecan Revenue (Million USD) by Players (2014-2019)

Table Global Topotecan Revenue Share by Players (2014-2019)

Figure Global Topotecan Revenue Share by Players in 2017

Figure Global Topotecan Revenue Share by Players in 2018

Figure Global Top 5 Players Topotecan Revenue Market Share in 2018

Figure Global Top 10 Players Topotecan Revenue Market Share in 2018

Figure Global Topotecan Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Topotecan Revenue (Million USD) by Regions (2014-2019)

Table Global Topotecan Revenue Market Share by Regions (2014-2019)

Figure Global Topotecan Revenue Market Share by Regions (2014-2019)

Figure Global Topotecan Revenue Market Share by Regions in 2018

Figure North America Topotecan Revenue and Growth Rate (2014-2019)

Figure Europe Topotecan Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Topotecan Revenue and Growth Rate (2014-2019)

Figure South America Topotecan Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Topotecan Revenue and Growth Rate (2014-2019)

Table North America Topotecan Revenue by Countries (2014-2019)

Table North America Topotecan Revenue Market Share by Countries (2014-2019)

Figure North America Topotecan Revenue Market Share by Countries (2014-2019)

Figure North America Topotecan Revenue Market Share by Countries in 2018

Figure USA Topotecan Revenue and Growth Rate (2014-2019)

Figure Canada Topotecan Revenue and Growth Rate (2014-2019)

Figure Mexico Topotecan Revenue and Growth Rate (2014-2019)

Table Europe Topotecan Revenue (Million USD) by Countries (2014-2019)

Figure Europe Topotecan Revenue Market Share by Countries (2014-2019)

Figure Europe Topotecan Revenue Market Share by Countries in 2018

Figure Germany Topotecan Revenue and Growth Rate (2014-2019)

Figure UK Topotecan Revenue and Growth Rate (2014-2019)

Figure France Topotecan Revenue and Growth Rate (2014-2019)

Figure Russia Topotecan Revenue and Growth Rate (2014-2019)

Figure Italy Topotecan Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Topotecan Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Topotecan Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Topotecan Revenue Market Share by Countries in 2018

Figure China Topotecan Revenue and Growth Rate (2014-2019)

Figure Japan Topotecan Revenue and Growth Rate (2014-2019)

Figure Korea Topotecan Revenue and Growth Rate (2014-2019)

Figure India Topotecan Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Topotecan Revenue and Growth Rate (2014-2019)

Table South America Topotecan Revenue by Countries (2014-2019)

Table South America Topotecan Revenue Market Share by Countries (2014-2019)

Figure South America Topotecan Revenue Market Share by Countries (2014-2019)

Figure South America Topotecan Revenue Market Share by Countries in 2018

Figure Brazil Topotecan Revenue and Growth Rate (2014-2019)

Figure Argentina Topotecan Revenue and Growth Rate (2014-2019)

Figure Colombia Topotecan Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Topotecan Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Topotecan Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Topotecan Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Topotecan Revenue Market Share by Countries in 2018

Figure Saudi Arabia Topotecan Revenue and Growth Rate (2014-2019)

Figure UAE Topotecan Revenue and Growth Rate (2014-2019)

Figure Egypt Topotecan Revenue and Growth Rate (2014-2019)

Figure Nigeria Topotecan Revenue and Growth Rate (2014-2019)

Figure South Africa Topotecan Revenue and Growth Rate (2014-2019)

Table Global Topotecan Revenue (Million USD) by Type (2014-2019)

Table Global Topotecan Revenue Share by Type (2014-2019)

Figure Global Topotecan Revenue Share by Type (2014-2019)

Figure Global Topotecan Revenue Share by Type in 2019

Table Global Topotecan Revenue Forecast by Type (2019-2024)

Figure Global Topotecan Market Share Forecast by Type (2019-2024)

Figure Global Capsules Revenue Growth Rate (2014-2019)

Figure Global Injection Revenue Growth Rate (2014-2019)

Table Global Topotecan Revenue by Application (2014-2019)

Table Global Topotecan Revenue Share by Application (2014-2019)

Figure Global Topotecan Revenue Share by Application (2014-2019)

Figure Global Topotecan Revenue Share by Application in 2019

Table Global Topotecan Revenue Forecast by Application (2019-2024)

Figure Global Topotecan Market Share Forecast by Application (2019-2024)

Figure Global Ovarian Cancer Revenue Growth Rate (2014-2019)

Figure Global Lung Cancer Revenue Growth Rate (2014-2019)

Figure Global Other Cancer types Revenue Growth Rate (2014-2019)

Figure Global Topotecan Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Topotecan Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Topotecan Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Topotecan Revenue Market Forecast (2019-2024)

Figure Europe Topotecan Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Topotecan Revenue Market Forecast (2019-2024)

Figure South America Topotecan Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Topotecan Revenue Market Forecast (2019-2024)

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

GSK

Teva

Fresenius Kabi

Cipla

Sagent Pharmaceuticals

Mylan

Pfizer

Dr. Reddy's Laboratories

Company Profile

Company Profile Title

Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types.

Scope of the Report:

The global Topotecan market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Topotecan.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Topotecan market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Topotecan market by product type and applications/end industries.

Market Segment by Companies, this report covers

GSK

Teva

Fresenius Kabi

Cipla

Sagent Pharmaceuticals

Mylan

Pfizer

Dr. Reddy's Laboratories

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Capsules

Injection

Market Segment by Applications, can be divided into

Ovarian Cancer

Lung Cancer

Other Cancer types

READ MORE

Scope

Table of Contents

1 Topotecan Market Overview

1.1 Product Overview and Scope of Topotecan

1.2 Classification of Topotecan by Types

1.2.1 Global Topotecan Revenue Comparison by Types (2019-2024)

1.2.2 Global Topotecan Revenue Market Share by Types in 2018

1.2.3 Capsules

1.2.4 Injection

1.3 Global Topotecan Market by Application

1.3.1 Global Topotecan Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Ovarian Cancer

1.3.3 Lung Cancer

1.3.4 Other Cancer types

1.4 Global Topotecan Market by Regions

1.4.1 Global Topotecan Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Topotecan Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Topotecan Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Topotecan Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Topotecan Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Topotecan Status and Prospect (2014-2024)

1.5 Global Market Size of Topotecan (2014-2024)

2 Manufacturers Profiles

2.1 GSK

2.1.1 Business Overview

2.1.2 Topotecan Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 GSK Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.2 Teva

2.2.1 Business Overview

2.2.2 Topotecan Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Teva Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.3 Fresenius Kabi

2.3.1 Business Overview

2.3.2 Topotecan Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Fresenius Kabi Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.4 Cipla

2.4.1 Business Overview

2.4.2 Topotecan Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Cipla Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.5 Sagent Pharmaceuticals

2.5.1 Business Overview

2.5.2 Topotecan Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Sagent Pharmaceuticals Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.6 Mylan

2.6.1 Business Overview

2.6.2 Topotecan Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Mylan Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.7 Pfizer

2.7.1 Business Overview

2.7.2 Topotecan Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Pfizer Topotecan Revenue, Gross Margin and Market Share (2017-2018)

2.8 Dr. Reddy's Laboratories

2.8.1 Business Overview

2.8.2 Topotecan Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Dr. Reddy's Laboratories Topotecan Revenue, Gross Margin and Market Share (2017-2018)

3 Global Topotecan Market Competition, by Players

3.1 Global Topotecan Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Topotecan Players Market Share

3.2.2 Top 10 Topotecan Players Market Share

3.3 Market Competition Trend

4 Global Topotecan Market Size by Regions

4.1 Global Topotecan Revenue and Market Share by Regions

4.2 North America Topotecan Revenue and Growth Rate (2014-2019)

4.3 Europe Topotecan Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Topotecan Revenue and Growth Rate (2014-2019)

4.5 South America Topotecan Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Topotecan Revenue and Growth Rate (2014-2019)

5 North America Topotecan Revenue by Countries

5.1 North America Topotecan Revenue by Countries (2014-2019)

5.2 USA Topotecan Revenue and Growth Rate (2014-2019)

5.3 Canada Topotecan Revenue and Growth Rate (2014-2019)

5.4 Mexico Topotecan Revenue and Growth Rate (2014-2019)

6 Europe Topotecan Revenue by Countries

6.1 Europe Topotecan Revenue by Countries (2014-2019)

6.2 Germany Topotecan Revenue and Growth Rate (2014-2019)

6.3 UK Topotecan Revenue and Growth Rate (2014-2019)

6.4 France Topotecan Revenue and Growth Rate (2014-2019)

6.5 Russia Topotecan Revenue and Growth Rate (2014-2019)

6.6 Italy Topotecan Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Topotecan Revenue by Countries

7.1 Asia-Pacific Topotecan Revenue by Countries (2014-2019)

7.2 China Topotecan Revenue and Growth Rate (2014-2019)

7.3 Japan Topotecan Revenue and Growth Rate (2014-2019)

7.4 Korea Topotecan Revenue and Growth Rate (2014-2019)

7.5 India Topotecan Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Topotecan Revenue and Growth Rate (2014-2019)

8 South America Topotecan Revenue by Countries

8.1 South America Topotecan Revenue by Countries (2014-2019)

8.2 Brazil Topotecan Revenue and Growth Rate (2014-2019)

8.3 Argentina Topotecan Revenue and Growth Rate (2014-2019)

8.4 Colombia Topotecan Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Topotecan by Countries

9.1 Middle East and Africa Topotecan Revenue by Countries (2014-2019)

9.2 Saudi Arabia Topotecan Revenue and Growth Rate (2014-2019)

9.3 UAE Topotecan Revenue and Growth Rate (2014-2019)

9.4 Egypt Topotecan Revenue and Growth Rate (2014-2019)

9.5 Nigeria Topotecan Revenue and Growth Rate (2014-2019)

9.6 South Africa Topotecan Revenue and Growth Rate (2014-2019)

10 Global Topotecan Market Segment by Type

10.1 Global Topotecan Revenue and Market Share by Type (2014-2019)

10.2 Global Topotecan Market Forecast by Type (2019-2024)

10.3 Capsules Revenue Growth Rate (2014-2024)

10.4 Injection Revenue Growth Rate (2014-2024)

11 Global Topotecan Market Segment by Application

11.1 Global Topotecan Revenue Market Share by Application (2014-2019)

11.2 Topotecan Market Forecast by Application (2019-2024)

11.3 Ovarian Cancer Revenue Growth (2014-2019)

11.4 Lung Cancer Revenue Growth (2014-2019)

11.5 Other Cancer types Revenue Growth (2014-2019)

12 Global Topotecan Market Size Forecast (2019-2024)

12.1 Global Topotecan Market Size Forecast (2019-2024)

12.2 Global Topotecan Market Forecast by Regions (2019-2024)

12.3 North America Topotecan Revenue Market Forecast (2019-2024)

12.4 Europe Topotecan Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Topotecan Revenue Market Forecast (2019-2024)

12.6 South America Topotecan Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Topotecan Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source


List Of Table

List of Tables and Figures

Figure Topotecan Picture

Table Product Specifications of Topotecan

Table Global Topotecan and Revenue (Million USD) Market Split by Product Type

Figure Global Topotecan Revenue Market Share by Types in 2018

Figure Capsules Picture

Figure Injection Picture

Table Global Topotecan Revenue (Million USD) by Application (2014-2024)

Figure Topotecan Revenue Market Share by Applications in 2018

Figure Ovarian Cancer Picture

Figure Lung Cancer Picture

Figure Other Cancer types Picture

Table Global Market Topotecan Revenue (Million USD) Comparison by Regions 2014-2024

Figure North America Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Figure Europe Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Figure Asia-Pacific Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Figure South America Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Figure Middle East and Africa Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Figure Global Topotecan Revenue (Million USD) and Growth Rate (2014-2024)

Table GSK Basic Information, Manufacturing Base and Competitors

Table GSK Topotecan Type and Applications

Table GSK Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Teva Basic Information, Manufacturing Base and Competitors

Table Teva Topotecan Type and Applications

Table Teva Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Fresenius Kabi Basic Information, Manufacturing Base and Competitors

Table Fresenius Kabi Topotecan Type and Applications

Table Fresenius Kabi Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Cipla Basic Information, Manufacturing Base and Competitors

Table Cipla Topotecan Type and Applications

Table Cipla Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Sagent Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Sagent Pharmaceuticals Topotecan Type and Applications

Table Sagent Pharmaceuticals Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Mylan Basic Information, Manufacturing Base and Competitors

Table Mylan Topotecan Type and Applications

Table Mylan Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Pfizer Basic Information, Manufacturing Base and Competitors

Table Pfizer Topotecan Type and Applications

Table Pfizer Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors

Table Dr. Reddy's Laboratories Topotecan Type and Applications

Table Dr. Reddy's Laboratories Topotecan Revenue, Gross Margin and Market Share (2017-2018)

Table Global Topotecan Revenue (Million USD) by Players (2014-2019)

Table Global Topotecan Revenue Share by Players (2014-2019)

Figure Global Topotecan Revenue Share by Players in 2017

Figure Global Topotecan Revenue Share by Players in 2018

Figure Global Top 5 Players Topotecan Revenue Market Share in 2018

Figure Global Top 10 Players Topotecan Revenue Market Share in 2018

Figure Global Topotecan Revenue (Million USD) and Growth Rate (%) (2014-2019)

Table Global Topotecan Revenue (Million USD) by Regions (2014-2019)

Table Global Topotecan Revenue Market Share by Regions (2014-2019)

Figure Global Topotecan Revenue Market Share by Regions (2014-2019)

Figure Global Topotecan Revenue Market Share by Regions in 2018

Figure North America Topotecan Revenue and Growth Rate (2014-2019)

Figure Europe Topotecan Revenue and Growth Rate (2014-2019)

Figure Asia-Pacific Topotecan Revenue and Growth Rate (2014-2019)

Figure South America Topotecan Revenue and Growth Rate (2014-2019)

Figure Middle East and Africa Topotecan Revenue and Growth Rate (2014-2019)

Table North America Topotecan Revenue by Countries (2014-2019)

Table North America Topotecan Revenue Market Share by Countries (2014-2019)

Figure North America Topotecan Revenue Market Share by Countries (2014-2019)

Figure North America Topotecan Revenue Market Share by Countries in 2018

Figure USA Topotecan Revenue and Growth Rate (2014-2019)

Figure Canada Topotecan Revenue and Growth Rate (2014-2019)

Figure Mexico Topotecan Revenue and Growth Rate (2014-2019)

Table Europe Topotecan Revenue (Million USD) by Countries (2014-2019)

Figure Europe Topotecan Revenue Market Share by Countries (2014-2019)

Figure Europe Topotecan Revenue Market Share by Countries in 2018

Figure Germany Topotecan Revenue and Growth Rate (2014-2019)

Figure UK Topotecan Revenue and Growth Rate (2014-2019)

Figure France Topotecan Revenue and Growth Rate (2014-2019)

Figure Russia Topotecan Revenue and Growth Rate (2014-2019)

Figure Italy Topotecan Revenue and Growth Rate (2014-2019)

Table Asia-Pacific Topotecan Revenue (Million USD) by Countries (2014-2019)

Figure Asia-Pacific Topotecan Revenue Market Share by Countries (2014-2019)

Figure Asia-Pacific Topotecan Revenue Market Share by Countries in 2018

Figure China Topotecan Revenue and Growth Rate (2014-2019)

Figure Japan Topotecan Revenue and Growth Rate (2014-2019)

Figure Korea Topotecan Revenue and Growth Rate (2014-2019)

Figure India Topotecan Revenue and Growth Rate (2014-2019)

Figure Southeast Asia Topotecan Revenue and Growth Rate (2014-2019)

Table South America Topotecan Revenue by Countries (2014-2019)

Table South America Topotecan Revenue Market Share by Countries (2014-2019)

Figure South America Topotecan Revenue Market Share by Countries (2014-2019)

Figure South America Topotecan Revenue Market Share by Countries in 2018

Figure Brazil Topotecan Revenue and Growth Rate (2014-2019)

Figure Argentina Topotecan Revenue and Growth Rate (2014-2019)

Figure Colombia Topotecan Revenue and Growth Rate (2014-2019)

Table Middle East and Africa Topotecan Revenue (Million USD) by Countries (2014-2019)

Table Middle East and Africa Topotecan Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Topotecan Revenue Market Share by Countries (2014-2019)

Figure Middle East and Africa Topotecan Revenue Market Share by Countries in 2018

Figure Saudi Arabia Topotecan Revenue and Growth Rate (2014-2019)

Figure UAE Topotecan Revenue and Growth Rate (2014-2019)

Figure Egypt Topotecan Revenue and Growth Rate (2014-2019)

Figure Nigeria Topotecan Revenue and Growth Rate (2014-2019)

Figure South Africa Topotecan Revenue and Growth Rate (2014-2019)

Table Global Topotecan Revenue (Million USD) by Type (2014-2019)

Table Global Topotecan Revenue Share by Type (2014-2019)

Figure Global Topotecan Revenue Share by Type (2014-2019)

Figure Global Topotecan Revenue Share by Type in 2019

Table Global Topotecan Revenue Forecast by Type (2019-2024)

Figure Global Topotecan Market Share Forecast by Type (2019-2024)

Figure Global Capsules Revenue Growth Rate (2014-2019)

Figure Global Injection Revenue Growth Rate (2014-2019)

Table Global Topotecan Revenue by Application (2014-2019)

Table Global Topotecan Revenue Share by Application (2014-2019)

Figure Global Topotecan Revenue Share by Application (2014-2019)

Figure Global Topotecan Revenue Share by Application in 2019

Table Global Topotecan Revenue Forecast by Application (2019-2024)

Figure Global Topotecan Market Share Forecast by Application (2019-2024)

Figure Global Ovarian Cancer Revenue Growth Rate (2014-2019)

Figure Global Lung Cancer Revenue Growth Rate (2014-2019)

Figure Global Other Cancer types Revenue Growth Rate (2014-2019)

Figure Global Topotecan Revenue (Million USD) and Growth Rate Forecast (2019-2024)

Table Global Topotecan Revenue (Million USD) Forecast by Regions (2019-2024)

Figure Global Topotecan Revenue Market Share Forecast by Regions (2019-2024)

Figure North America Topotecan Revenue Market Forecast (2019-2024)

Figure Europe Topotecan Revenue Market Forecast (2019-2024)

Figure Asia-Pacific Topotecan Revenue Market Forecast (2019-2024)

Figure South America Topotecan Revenue Market Forecast (2019-2024)

Figure Middle East and Africa Topotecan Revenue Market Forecast (2019-2024)

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

GSK

Teva

Fresenius Kabi

Cipla

Sagent Pharmaceuticals

Mylan

Pfizer

Dr. Reddy's Laboratories